Date | Insider | Price | Amount |
---|---|---|---|
5-26-2020 Insider Buy |
Michael D. Clayman President and CEO |
$9.75 CAGR » |
$99,996.00 10,256 shares |
5-26-2020 Insider Buy |
Mark Stejbach Director |
$9.75 CAGR » |
$19,997.25 2,051 shares |
5-31-2019 Insider Buy |
David Arkowitz Chief Financial Officer |
$11.05 CAGR » |
$27,626.75 2,500 shares |
8-8-2019 Insider Buy |
Michael D. Clayman President and CEO |
$10.85 CAGR » |
$25,136.21 2,317 shares |
5-23-2019 Insider Buy |
C. Ann Merrifield Director |
$12.64 CAGR » |
$101,120.00 8,000 shares |
5-13-2019 Insider Buy |
David Arkowitz Chief Financial Officer |
$11.99 CAGR » |
$47,960.00 4,000 shares |
5-10-2019 Insider Buy |
Michael D. Clayman President and CEO |
$12.48 CAGR » |
$50,067.35 4,012 shares |
3-12-2019 Insider Buy |
Michael D. Clayman President and CEO |
$12.36 CAGR » |
$50,008.56 4,046 shares |
11-9-2018 Insider Buy |
Michael D. Clayman President and CEO |
$17.10 CAGR » |
$85,476.50 5,000 shares |
11-9-2018 Insider Buy |
David Arkowitz Chief Financial Officer |
$16.56 CAGR » |
$66,221.60 4,000 shares |
8-9-2018 Insider Buy |
David Arkowitz Chief Financial Officer |
$23.42 CAGR » |
$93,680.00 4,000 shares |
8-9-2018 Insider Buy |
Michael D. Clayman President and CEO |
$22.33 CAGR » |
$223,300.00 10,000 shares |
11-21-2017 Insider Buy |
Neil Bodick Chief Scientific Officer |
$24.49 CAGR » |
$66,112.24 2,700 shares |
11-8-2017 Insider Buy |
Michael D. Clayman President and CEO |
$23.60 CAGR » |
$118,000.00 5,000 shares |
9-5-2017 Insider Buy |
Yamo Deniz Chief Medical Officer |
$24.48 CAGR » |
$131,575.00 5,375 shares |
6-16-2017 Insider Buy |
Mark Stejbach Director |
$17.02 CAGR » |
$26,888.12 1,580 shares |
6-5-2017 Insider Buy |
Michael D. Clayman President and CEO |
$17.23 CAGR » |
$86,151.50 5,000 shares |
12-1-2016 Insider Buy |
Samuel D. Colella Director and >10% Owner |
$16.38 CAGR » |
$163,807.00 10,000 shares |
11-23-2016 Insider Buy |
Michael D. Clayman President and CEO |
$18.41 CAGR » |
$30,688.30 1,667 shares |
11-22-2016 Insider Buy |
Michael D. Clayman President and CEO |
$17.95 CAGR » |
$29,900.20 1,666 shares |
11-21-2016 Insider Buy |
Samuel D. Colella Director and >10% Owner |
$18.00 CAGR » |
$599,994.00 33,333 shares |
11-21-2016 Insider Buy |
Michael D. Clayman President and CEO |
$17.90 CAGR » |
$29,827.40 1,666 shares |
6-14-2016 Insider Buy |
C. Ann Merrifield Director |
$13.39 CAGR » |
$13,387.00 1,000 shares |
6-8-2016 Insider Buy |
Versant Ventures III, LLC >10% Owner |
$14.00 CAGR » |
$9,999,990.00 714,285 shares |
6-8-2016 Insider Buy |
Barbara N. Lubash >10% Owner |
$14.00 CAGR » |
$9,999,990.00 714,285 shares |
5-20-2016 Insider Buy |
Michael D. Clayman President and CEO |
$10.41 CAGR » |
$20,810.40 2,000 shares |
5-19-2016 Insider Buy |
Michael D. Clayman President and CEO |
$9.65 CAGR » |
$19,297.20 2,000 shares |
5-18-2016 Insider Buy |
Michael D. Clayman President and CEO |
$10.23 CAGR » |
$20,465.00 2,000 shares |
5-17-2016 Insider Buy |
Michael D. Clayman President and CEO |
$9.73 CAGR » |
$19,465.00 2,000 shares |
5-17-2016 Insider Buy |
Michael D. Clayman President and CEO |
$9.73 CAGR » |
$19,465.00 2,000 shares |
5-17-2016 Insider Buy |
Frederick W. Driscoll Chief Financial Officer |
$9.87 CAGR » |
$24,668.00 2,500 shares |
5-16-2016 Insider Buy |
Michael D. Clayman President and CEO |
$9.51 CAGR » |
$19,025.00 2,000 shares |
5-16-2016 Insider Buy |
Frederick W. Driscoll Chief Financial Officer |
$9.19 CAGR » |
$22,971.75 2,500 shares |
9-11-2015 Insider Buy |
C. Ann Merrifield Director |
$23.00 CAGR » |
$23,000.00 1,000 shares |
12-17-2014 Insider Buy |
A/S Novo >10% Owner |
$17.00 CAGR » |
$8,500,000.00 500,000 shares |
2-18-2014 Insider Buy |
A/S Novo >10% Owner |
$13.00 CAGR » |
$9,000,004.00 692,308 shares |
2-18-2014 Insider Buy |
Bradley J. Phd Bolzon Director and >10% Owner |
$13.00 CAGR » |
$3,999,996.00 307,692 shares |
2-18-2014 Insider Buy |
Samuel D. Colella Director and >10% Owner |
$13.00 CAGR » |
$3,999,996.00 307,692 shares |
2-18-2014 Insider Buy |
Partners Sas Sofinnova >10% Owner |
$13.00 CAGR » |
$2,999,997.00 230,769 shares |
2-18-2014 Insider Buy |
Rafael Tordjman Director and >10% Owner |
$13.00 CAGR » |
$2,999,997.00 230,769 shares |
2-18-2014 Insider Buy |
Versant Venture Capital III, L.P. >10% Owner |
$13.00 CAGR » |
$3,999,996.00 307,692 shares |
Also See: Institutional Holders of FLXN
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/27/2020 | |
End date: | 11/19/2021 | |
Start price/share: | $10.33 | |
End price/share: | $9.12 | |
Dividends collected/share: | $0.00 | |
Total return: | -11.71% | |
Average Annual Total Return: | -8.06% | |
Starting investment: | $10,000.00 | |
Ending investment: | $8,828.90 | |
Years: | 1.48 |
FLXN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent FLXN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding FLXN
Free FLXN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |